The Degree of Anisocytosis Predicts Survival in Patients with Primary Myelofibrosis

Publisher： Karger

E-ISSN： 1421-9662|136|2|98-100

ISSN： 0001-5792

Source： Acta Haematologica, Vol.136, Iss.2, 2016-05, pp. : 98-100

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Anisocytosis: A Classical Marker of Inflammation or a New Predictive Marker in Patients with Primary Myelofibrosis

By  

Acta Haematologica, Vol. 136, Iss. 3, 2016-09 ,pp. : 191-192

Karger

Access to resources Recommend Favorite

Comorbidities predict worse prognosis in patients with primary myelofibrosis

By  

CANCER, Vol. 120, Iss. 19, 2014-10 ,pp. : 2996-3002

John Wiley & Sons Inc

Access to resources Recommend Favorite

Significance of thrombocytopenia in patients with primary and postessential thrombocythemia/polycythemia vera myelofibrosis

By  

EUROPEAN JOURNAL OF HAEMATOLOGY, Vol. 100, Iss. 3, 2018-03 ,pp. : 257-263

John Wiley & Sons Inc

Access to resources Recommend Favorite

Metastasis initiating cells in primary prostate cancer tissues from transurethral resection of the prostate (TURP) predicts castration‐resistant progression and survival of prostate cancer patients

By  

THE PROSTATE, Vol. 75, Iss. 12, 2015-07 ,pp. : 1312-1321

John Wiley & Sons Inc

Access to resources Recommend Favorite

Driver mutations and prognosis in primary myelofibrosis: Mayo‐Careggi MPN alliance study of 1,095 patients

By  

AMERICAN JOURNAL OF HEMATOLOGY, Vol. 93, Iss. 3, 2018-03 ,pp. : 348-355

John Wiley & Sons Inc

Access to resources Recommend Favorite